Dermira Secures $35,000,000 Series B Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=988192d2-b4e9-420e-81ef-8d9c294ffecd&Preview=1
Date
6/12/2013
Company Name
Dermira
Mailing Address
2055 Woodside Road Redwood City, CA 94061
Company Description
Dermira is a development-stage, private biotech company focused on developing and commercializing innovative new therapies in dermatology. Dermira was founded by an experienced management team and owns and licenses a robust pipeline of innovative topical compounds addressing areas of need in dermatology. Our lead product candidate, lemuteporfin (LTS), is currently in clinical trials for acne.
Website
http://www.dermira.com
Transaction Type
Venture Equity
Transaction Amount
$35,000,000
Transaction Round
Series B
Proceeds Purposes
These new funds provide Dermira with the resources required to continue to advance its robust pipeline of novel therapeutics for serious dermatological conditions.
M&A Terms
Venture Investor
Maruho
Venture Investor
Bay City Capital
Venture Investor
New Enterprise Associates
Venture Investor
Canaan Partners